GORDEEVA, A.V.,
SITDIKOVA, I.D.,
GALIMOVA, I.A.,
GUREVSKAYA, O.А.,
USMANOVA, I.N.,
DETOCHKINA, V.R. (2019) , the development of differentiated treatment
regimens and rehabilitation of patients with pathology
Yunusbaeva, M.,
Borodina, L.,
Alekseev, P.,
Davydov, R.,
Sharipov, R.,
Bilalov, F.,
Yunusbayev, B. (2019) for these countries are limited, and it is not clear whether current treatment
regimens remain effective against
LATYPOVA, G.M.,
BYCHENKOVA, M.A.,
KATAYEV, V.A.,
PERFILOVA, V.N.,
TYURENKOV, I.N.,
MOKROUSOV, I.S.,
PROKOFIEV, I.I.,
SALIKHOV, SH.M.,
IKSANOVA, G.R. (2019) ), and nuclear magnetic resonance spectroscopy (NMRS). To model CHF, L-isoproterenol at a
dose of 2.5 mg